(0.39%) 5 175.00 points
(0.36%) 38 970 points
(0.32%) 18 059 points
(0.86%) $78.78
(1.91%) $2.18
(0.73%) $2 325.50
(2.20%) $27.28
(0.65%) $971.60
(-0.17%) $0.927
(-0.53%) $10.82
(-0.32%) $0.794
(-0.33%) $91.15
Live Chart Being Loaded With Signals
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally...
Stats | |
---|---|
本日の出来高 | 543 145 |
平均出来高 | 3.71M |
時価総額 | 4.52M |
EPS | $0 ( 2024-03-19 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.436 |
ATR14 | $0.224 (224.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-05 | Goldentree Asset Management Lp | Buy | 75 000 | Ordinary Shares |
2023-12-04 | Goldentree Asset Management Lp | Buy | 0 | Ordinary Shares |
2023-11-14 | Zinman Jon | Buy | 0 | |
2023-11-14 | Stetson David J. | Buy | 0 | |
2023-11-14 | Bracebridge Capital, Llc | Buy | 1 093 857 | New Common Stock |
INSIDER POWER |
---|
-27.49 |
Last 92 transactions |
Buy: 3 785 978 | Sell: 4 853 818 |
ボリューム 相関
Mallinckrodt plc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Mallinckrodt plc 相関 - 通貨/商品
Mallinckrodt plc 財務諸表
Annual | 2022 |
収益: | $2.21B |
総利益: | $891.70M (40.37 %) |
EPS: | $-8.47 |
FY | 2022 |
収益: | $2.21B |
総利益: | $891.70M (40.37 %) |
EPS: | $-8.47 |
FY | 2021 |
収益: | $2.21B |
総利益: | $891.70M (40.37 %) |
EPS: | $-8.47 |
FY | 2020 |
収益: | $2.21B |
総利益: | $669.40M (30.24 %) |
EPS: | $-11.18 |
Financial Reports:
No articles found.
Mallinckrodt plc
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products. It offers Acthar Gel, a repository corticotropin injection for rheumatoid arthritis, infantile spasms, systemic lupus erythematosus, multiple sclerosis, systemic dermatomyositis, symptomatic sarcoidosis, severe acute and chronic allergic, and inflammatory diseases; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Therakos photopheresis, an immunotherapy treatment platform; Amitiza for constipation; and StrataGraft for the treatment of adults with deep partial-thickness burns. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; and SLN 501 is a ribonucleic acid silencing therap. In addition, it provides specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, respiratory therapists, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc to develop and commercialize ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。